Correlations between noninvasive tests as predictors of liver fibrosis and of viral response in chronic hepatitis C patients by Oana Streinu-Cercel et al.
POSTER PRESENTATION Open Access
Correlations between noninvasive tests as
predictors of liver fibrosis and of viral response in
chronic hepatitis C patients
Oana Streinu-Cercel1,2*, Elena-Sînziana Daia2,3, Mihail Tiberiu Daia2, Anca Streinu-Cercel1,2, Tania Gudu3,
Adrian Streinu-Cercel1,2
From The 9th Edition of the Scientific Days of the National Institute for Infectious Diseases Prof Dr Matei Bals
Bucharest, Romania. 23-25 October 2013
Background
The noninvasive assessment of liver fibrosis in chronic
hepatitis C patients is very important as it dictates the dis-
ease prognosis and the indication for therapy, narrowing
down the use of the liver biopsy. Standardized scores
(FibroTest, FibroMax) and imaging techniques (FibroScan)
have been validated in this respect. As for the noninvasive
prediction of the sustained viral response (SVR), GenoFi-
broTest and Prometheus are two indexes that may be
used. This study’s aim is to compare several biological
scores with these standardized scores for evaluating fibro-
sis and the two indexes for prediction of SVR.
Methods
We performed a cross-sectional analysis on a group of
patients with chronic hepatitis C evaluated at the National
Institute for Infectious Diseases “Prof. Dr. Matei Balş”. We
assessed serum tests, FibroScan, FibroTest and IL28B
polymorphism. We calculated several biological scores
(APRI, Lok, Forn’s, FIB-4 and Bonacini) and compared
them with each other and with FibroScan/FibroTest and
we calculated and compared the GenoFibroTest and
Prometheus indexes, verifying the statistic correlation of
the results.
Results
The study included 56 patients (of which 26 were males);
the median age was 52±12 years. The median necroin-
flammatory activity was 0.58±0.25, as evaluated through
ActiTest. The median FibroTest values were 0.55±0.30
while the median FibroScan scores were 8.8±9.7 kPa. The
areas under the receiver operating characteristic (AUROC)
for APRI, Lok, Forn’s, FIB-4, Bonacini scores and Fibro-
Scan, compared to FibroTest were 0.70, 0.78, 0.85, 0.80,
0.78 and 0.71 respectively, for F≥2; and 0.83, 0.79, 0.92,
0.86, 0.77 and 0.77, respectively, for F=4. As for the predic-
tion of SVR, for a cut-off of GenoFibroTest of 0.4,
Prometheus index’s AUROC was 0.85.
Conclusion
All the evaluated scores had excellent predictive value, with
Forn’s being the best biological score, especially for the
assessment of significant fibrosis (F2-F4). Prometheus index
had a good predictive value of the patients that could bene-
fit only from double therapy, in the context of the triple
association. If more non-invasive tests could be standar-
dized, the stage of fibrosis and the SVR could be easily esti-
mated, and the need for biopsy could be narrowed down.
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